Regencell Bioscience Holdings Limited (NASDAQ: RGC)
$5.0200
-0.1530 ( -3.07% ) 0.1K
Regencell Bioscience Holdings Ltd is engaged in the research, development and commercialization of traditional Chinese medicine. The medicines are used for the treatment of neurocognitive disorders and degeneration.
Market Data
Open
$5.0200
Previous close
$5.1730
Volume
0.1K
Market cap
$67.32M
Day range
$5.1790 - $5.5000
52 week range
$3.0300 - $32.4400
SEC Filings
| Form Type | Description | Pages | Date |
|---|---|---|---|
| 20-f | Annual reports | 72 | Oct 25, 2024 |
| 6-k | Form 6-K | 2 | Jun 20, 2024 |
| 6-k | Form 6-K | 2 | Jan 02, 2024 |
| 6-k | Form 6-K | 2 | Dec 15, 2023 |